Proactiveinvestors USA & Canada VolitionRx https://www.proactiveinvestors.com Proactiveinvestors USA & Canada VolitionRx RSS feed en Fri, 04 Dec 2020 18:49:56 -0500 http://blogs.law.harvard.edu/tech/rss Genera CMS action@proactiveinvestors.com (Proactiveinvestors) action@proactiveinvestors.com (Proactiveinvestors) VolitionRx welcomes Veterinary Centers of American executive Tom Butera to its board of directors https://www.proactiveinvestors.com/companies/news/935657/volitionrx-welcomes-veterinary-centers-of-american-executive-tom-butera-to-its-board-of-directors-935657.html Thu, 03 Dec 2020 14:47:00 -0500 https://www.proactiveinvestors.com/companies/news/935657/volitionrx-welcomes-veterinary-centers-of-american-executive-tom-butera-to-its-board-of-directors-935657.html VolitionRx launches reliable Nu.Q Vet Cancer Screening Test in the US https://www.proactiveinvestors.com/companies/news/935418/volitionrx-launches-reliable-nuq-vet-cancer-screening-test-in-the-us-935418.html Tue, 01 Dec 2020 18:40:00 -0500 https://www.proactiveinvestors.com/companies/news/935418/volitionrx-launches-reliable-nuq-vet-cancer-screening-test-in-the-us-935418.html VolitionRx to present Nu.Q coronavirus study data at MEDICA 2020 virtual forum https://www.proactiveinvestors.com/companies/news/934451/volitionrx-to-present-nuq-coronavirus-study-data-at-medica-2020-virtual-forum-934451.html Thu, 19 Nov 2020 16:29:00 -0500 https://www.proactiveinvestors.com/companies/news/934451/volitionrx-to-present-nuq-coronavirus-study-data-at-medica-2020-virtual-forum-934451.html VolitionRx ends 3Q with $21M in cash as it prepares to launch Nu.Q Vet Cancer Screening Test https://www.proactiveinvestors.com/companies/news/933935/volitionrx-ends-3q-with-21m-in-cash-as-it-prepares-to-launch-nuq-vet-cancer-screening-test-933935.html Fri, 13 Nov 2020 14:02:00 -0500 https://www.proactiveinvestors.com/companies/news/933935/volitionrx-ends-3q-with-21m-in-cash-as-it-prepares-to-launch-nuq-vet-cancer-screening-test-933935.html VolitionRx Limited ends its 3Q with $21M in the bank, looks forward to upcoming product launches https://www.proactiveinvestors.com/companies/news/933928/volitionrx-limited-ends-its-3q-with-21m-in-the-bank-looks-forward-to-upcoming-product-launches-933928.html Fri, 13 Nov 2020 13:27:00 -0500 https://www.proactiveinvestors.com/companies/news/933928/volitionrx-limited-ends-its-3q-with-21m-in-the-bank-looks-forward-to-upcoming-product-launches-933928.html VolitionRx says veterinary oncology experts contribute to report ahead of Nu.Q Vet Cancer Screening Test launch https://www.proactiveinvestors.com/companies/news/933624/volitionrx-says-veterinary-oncology-experts-contribute-to-report-ahead-of-nuq-vet-cancer-screening-test-launch-933624.html Tue, 10 Nov 2020 16:22:00 -0500 https://www.proactiveinvestors.com/companies/news/933624/volitionrx-says-veterinary-oncology-experts-contribute-to-report-ahead-of-nuq-vet-cancer-screening-test-launch-933624.html VolitionRx hosts virtual capital markets day event to discuss upcoming product launches https://www.proactiveinvestors.com/companies/news/931932/volitionrx-hosts-virtual-capital-markets-day-event-to-discuss-upcoming-product-launches-931932.html Tue, 20 Oct 2020 14:36:00 -0400 https://www.proactiveinvestors.com/companies/news/931932/volitionrx-hosts-virtual-capital-markets-day-event-to-discuss-upcoming-product-launches-931932.html VolitionRx to present canine cancer detection studies of its Nu.Q Vet Cancer Screening Test at veterinary conference this week https://www.proactiveinvestors.com/companies/news/931674/volitionrx-to-present-canine-cancer-detection-studies-of-its-nuq-vet-cancer-screening-test-at-veterinary-conference-this-week-931674.html Fri, 16 Oct 2020 13:08:00 -0400 https://www.proactiveinvestors.com/companies/news/931674/volitionrx-to-present-canine-cancer-detection-studies-of-its-nuq-vet-cancer-screening-test-at-veterinary-conference-this-week-931674.html VolitionRX progressing towards launch of first commercial products using Nu.Q platform https://www.proactiveinvestors.com/companies/news/926715/volitionrx-progressing-towards-launch-of-first-commercial-products-using-nuq-platform-926715.html Fri, 14 Aug 2020 10:48:00 -0400 https://www.proactiveinvestors.com/companies/news/926715/volitionrx-progressing-towards-launch-of-first-commercial-products-using-nuq-platform-926715.html VolitionRx on the path to launch first commercial products using Nu.Q platform as it ends 2Q with $21.3 million in cash https://www.proactiveinvestors.com/companies/news/926656/volitionrx-on-the-path-to-launch-first-commercial-products-using-nuq-platform-as-it-ends-2q-with-213-million-in-cash-926656.html Thu, 13 Aug 2020 20:58:00 -0400 https://www.proactiveinvestors.com/companies/news/926656/volitionrx-on-the-path-to-launch-first-commercial-products-using-nuq-platform-as-it-ends-2q-with-213-million-in-cash-926656.html Proactive One2One Virtual Event - VolitionRX https://www.proactiveinvestors.com/companies/news/926407/proactive-one2one-virtual-event---volitionrx-926407.html Tue, 11 Aug 2020 14:23:00 -0400 https://www.proactiveinvestors.com/companies/news/926407/proactive-one2one-virtual-event---volitionrx-926407.html VolitionRx to present coronavirus triage test advancements at Proactive's One2One Conference https://www.proactiveinvestors.com/companies/news/924754/volitionrx-to-present-coronavirus-triage-test-advancements-at-proactive-s-one2one-conference-924754.html Tue, 21 Jul 2020 15:35:00 -0400 https://www.proactiveinvestors.com/companies/news/924754/volitionrx-to-present-coronavirus-triage-test-advancements-at-proactive-s-one2one-conference-924754.html Small cap growth stocks in the spotlight at Proactive’s virtual event on July 21 https://www.proactiveinvestors.com/companies/news/924412/small-cap-growth-stocks-in-the-spotlight-at-proactives-virtual-event-on-july-21-924412.html Mon, 20 Jul 2020 19:00:00 -0400 https://www.proactiveinvestors.com/companies/news/924412/small-cap-growth-stocks-in-the-spotlight-at-proactives-virtual-event-on-july-21-924412.html Volition reports promising clinical trials results for its novel coronavirus triage test https://www.proactiveinvestors.com/companies/news/924165/volition-reports-promising-clinical-trials-results-for-its-novel-coronavirus-triage-test-924165.html Tue, 14 Jul 2020 11:09:00 -0400 https://www.proactiveinvestors.com/companies/news/924165/volition-reports-promising-clinical-trials-results-for-its-novel-coronavirus-triage-test-924165.html VolitionRx to join Russell 3000, Microcap Indexes https://www.proactiveinvestors.com/companies/news/922778/volitionrx-to-join-russell-3000-microcap-indexes-922778.html Thu, 25 Jun 2020 14:14:00 -0400 https://www.proactiveinvestors.com/companies/news/922778/volitionrx-to-join-russell-3000-microcap-indexes-922778.html VolitionRx CEO to present coronavirus white blood cell research at Maxim Group virtual conference https://www.proactiveinvestors.com/companies/news/920542/volitionrx-ceo-to-present-coronavirus-white-blood-cell-research-at-maxim-group-virtual-conference-920542.html Wed, 27 May 2020 15:21:00 -0400 https://www.proactiveinvestors.com/companies/news/920542/volitionrx-ceo-to-present-coronavirus-white-blood-cell-research-at-maxim-group-virtual-conference-920542.html VolitionRx closes $13.8M public offering to fund product development and clinical studies https://www.proactiveinvestors.com/companies/news/920407/volitionrx-closes-138m-public-offering-to-fund-product-development-and-clinical-studies-920407.html Tue, 26 May 2020 12:45:00 -0400 https://www.proactiveinvestors.com/companies/news/920407/volitionrx-closes-138m-public-offering-to-fund-product-development-and-clinical-studies-920407.html VolitionRx prices public offering to raise up to $13.8M to fund product development and clinical studies https://www.proactiveinvestors.com/companies/news/920074/volitionrx-prices-public-offering-to-raise-up-to-138m-to-fund-product-development-and-clinical-studies-920074.html Wed, 20 May 2020 14:05:00 -0400 https://www.proactiveinvestors.com/companies/news/920074/volitionrx-prices-public-offering-to-raise-up-to-138m-to-fund-product-development-and-clinical-studies-920074.html VolitionRx announces share offering to boost product development and clinical studies https://www.proactiveinvestors.com/companies/news/919981/volitionrx-announces-share-offering-to-boost-product-development-and-clinical-studies-919981.html Tue, 19 May 2020 20:15:00 -0400 https://www.proactiveinvestors.com/companies/news/919981/volitionrx-announces-share-offering-to-boost-product-development-and-clinical-studies-919981.html VolitionRx’s Nu.Q cancer-screening blood tests could replace colonoscopies, biopsies https://www.proactiveinvestors.com/companies/news/222612/volitionrxs-nuq-cancer-screening-blood-tests-could-replace-colonoscopies-biopsies-222612.html Fri, 15 May 2020 11:00:00 -0400 https://www.proactiveinvestors.com/companies/news/222612/volitionrxs-nuq-cancer-screening-blood-tests-could-replace-colonoscopies-biopsies-222612.html VolitionRx to share data on enhanced Nu.Q Capture, Nu.Q Assay performance in detecting lung and blood cancers at ASCO meeting https://www.proactiveinvestors.com/companies/news/919592/volitionrx-to-share-data-on-enhanced-nuq-capture-nuq-assay-performance-in-detecting-lung-and-blood-cancers-at-asco-meeting-919592.html Thu, 14 May 2020 12:05:00 -0400 https://www.proactiveinvestors.com/companies/news/919592/volitionrx-to-share-data-on-enhanced-nuq-capture-nuq-assay-performance-in-detecting-lung-and-blood-cancers-at-asco-meeting-919592.html VolitionRX encouraged by early data on its Nu.QTM blood test as potential tool against coronavirus https://www.proactiveinvestors.com/companies/news/919158/volitionrx-encouraged-by-early-data-on-its-nuqtm-blood-test-as-potential-tool-against-coronavirus-919158.html Fri, 08 May 2020 10:21:00 -0400 https://www.proactiveinvestors.com/companies/news/919158/volitionrx-encouraged-by-early-data-on-its-nuqtm-blood-test-as-potential-tool-against-coronavirus-919158.html VolitionRx closes 1Q with $12M in cash while studying Nu.Q blood test as potential coronavirus diagnostic tool https://www.proactiveinvestors.com/companies/news/919138/volitionrx-closes-1q-with-12m-in-cash-while-studying-nuq-blood-test-as-potential-coronavirus-diagnostic-tool-919138.html Thu, 07 May 2020 20:52:00 -0400 https://www.proactiveinvestors.com/companies/news/919138/volitionrx-closes-1q-with-12m-in-cash-while-studying-nuq-blood-test-as-potential-coronavirus-diagnostic-tool-919138.html VolitionRx welcomes proof of concept results as its Nu.Q assay detects two cancers common in dogs https://www.proactiveinvestors.com/companies/news/918434/volitionrx-welcomes-proof-of-concept-results-as-its-nuq-assay-detects-two-cancers-common-in-dogs-918434.html Wed, 29 Apr 2020 15:15:00 -0400 https://www.proactiveinvestors.com/companies/news/918434/volitionrx-welcomes-proof-of-concept-results-as-its-nuq-assay-detects-two-cancers-common-in-dogs-918434.html VolitionRx developing a proprietary coronavirus triage test https://www.proactiveinvestors.com/companies/news/918008/volitionrx-developing-a-proprietary-coronavirus-triage-test-918008.html Thu, 23 Apr 2020 19:39:00 -0400 https://www.proactiveinvestors.com/companies/news/918008/volitionrx-developing-a-proprietary-coronavirus-triage-test-918008.html VolitionRx actively developing coronavirus (COVID-19) triage test using its proprietary Nu.QTM platform https://www.proactiveinvestors.com/companies/news/917982/volitionrx-actively-developing-coronavirus-covid-19-triage-test-using-its-proprietary-nuqtm-platform-917982.html Thu, 23 Apr 2020 14:00:00 -0400 https://www.proactiveinvestors.com/companies/news/917982/volitionrx-actively-developing-coronavirus-covid-19-triage-test-using-its-proprietary-nuqtm-platform-917982.html VolitionRx CEO highlights 'very strong assay and platform development progress' https://www.proactiveinvestors.com/companies/news/913458/volitionrx-ceo-highlights--very-strong-assay-and-platform-development-progress--913458.html Fri, 21 Feb 2020 11:21:00 -0500 https://www.proactiveinvestors.com/companies/news/913458/volitionrx-ceo-highlights--very-strong-assay-and-platform-development-progress--913458.html VolitionRx CEO says company in 'strong position' to meet 2020 milestones https://www.proactiveinvestors.com/companies/news/913378/volitionrx-ceo-says-company-in--strong-position--to-meet-2020-milestones-913378.html Thu, 20 Feb 2020 21:35:00 -0500 https://www.proactiveinvestors.com/companies/news/913378/volitionrx-ceo-says-company-in--strong-position--to-meet-2020-milestones-913378.html VolitionRx unveils new epigenetic toolbox off new research into Nu.Q Capture program https://www.proactiveinvestors.com/companies/news/913161/volitionrx-unveils-new-epigenetic-toolbox-off-new-research-into-nuqcapture-program-913161.html Tue, 18 Feb 2020 16:27:00 -0500 https://www.proactiveinvestors.com/companies/news/913161/volitionrx-unveils-new-epigenetic-toolbox-off-new-research-into-nuqcapture-program-913161.html VolitionRx introduces new magnetic particle-based Nu.Q assay format https://www.proactiveinvestors.com/companies/news/910481/volitionrx-introduces-new-magnetic-particle-based-nuq-assay-format-910481.html Mon, 13 Jan 2020 15:29:00 -0500 https://www.proactiveinvestors.com/companies/news/910481/volitionrx-introduces-new-magnetic-particle-based-nuq-assay-format-910481.html